Global Nuclear Receptor ROR-Gamma Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 16-Jul-2021
No. of pages: 127
Inquire Before Buying

Market Analysis and Insights: Global Nuclear Receptor ROR-Gamma Market

The global Nuclear Receptor ROR-Gamma market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nuclear Receptor ROR-Gamma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nuclear Receptor ROR-Gamma market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nuclear Receptor ROR-Gamma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nuclear Receptor ROR-Gamma market.

Global Nuclear Receptor ROR-Gamma Scope and Market Size

Nuclear Receptor ROR-Gamma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Receptor ROR-Gamma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- VPR-66

- INV-17

- GSK-2981278

- BBI-6000

- Others

Segment by Application

- Hospital

- Clinic

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- 4SC AG

- Advinus Therapeutics Ltd.

- Arrien Pharmaceuticals, LLC

- Aurigene Discovery Technologies Limited

- Biogen, Inc.

- Brickell Biotech, Inc.

- Bristol-Myers Squibb Company

- Celgene Corporation

- Genentech, Inc.

- Genfit SA

- GlaxoSmithKline Plc

- Hanmi Pharmaceuticals, Co. Ltd.

- Karo Bio AB

- Lead Pharma Holding B.V.

- Nuevolution AB

- Phenex Pharmaceuticals AG

- Reata Pharmaceuticals, Inc.

- Teijin Pharma Limited

- Visionary Pharmaceuticals, Inc.

- Vitae Pharmaceuticals, Inc.

Global Nuclear Receptor ROR-Gamma Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 VPR-66
1.2.3 INV-17
1.2.4 GSK-2981278
1.2.5 BBI-6000
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nuclear Receptor ROR-Gamma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Receptor ROR-Gamma Market Perspective (2016-2027)
2.2 Nuclear Receptor ROR-Gamma Growth Trends by Regions
2.2.1 Nuclear Receptor ROR-Gamma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nuclear Receptor ROR-Gamma Historic Market Share by Regions (2016-2021)
2.2.3 Nuclear Receptor ROR-Gamma Forecasted Market Size by Regions (2022-2027)
2.3 Nuclear Receptor ROR-Gamma Industry Dynamic
2.3.1 Nuclear Receptor ROR-Gamma Market Trends
2.3.2 Nuclear Receptor ROR-Gamma Market Drivers
2.3.3 Nuclear Receptor ROR-Gamma Market Challenges
2.3.4 Nuclear Receptor ROR-Gamma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Receptor ROR-Gamma Players by Revenue
3.1.1 Global Top Nuclear Receptor ROR-Gamma Players by Revenue (2016-2021)
3.1.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Players (2016-2021)
3.2 Global Nuclear Receptor ROR-Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nuclear Receptor ROR-Gamma Revenue
3.4 Global Nuclear Receptor ROR-Gamma Market Concentration Ratio
3.4.1 Global Nuclear Receptor ROR-Gamma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Receptor ROR-Gamma Revenue in 2020
3.5 Nuclear Receptor ROR-Gamma Key Players Head office and Area Served
3.6 Key Players Nuclear Receptor ROR-Gamma Product Solution and Service
3.7 Date of Enter into Nuclear Receptor ROR-Gamma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Receptor ROR-Gamma Breakdown Data by Type
4.1 Global Nuclear Receptor ROR-Gamma Historic Market Size by Type (2016-2021)
4.2 Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Type (2022-2027)
5 Nuclear Receptor ROR-Gamma Breakdown Data by Application
5.1 Global Nuclear Receptor ROR-Gamma Historic Market Size by Application (2016-2021)
5.2 Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nuclear Receptor ROR-Gamma Market Size (2016-2027)
6.2 North America Nuclear Receptor ROR-Gamma Market Size by Type
6.2.1 North America Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021)
6.2.2 North America Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027)
6.2.3 North America Nuclear Receptor ROR-Gamma Market Size by Type (2016-2027)
6.3 North America Nuclear Receptor ROR-Gamma Market Size by Application
6.3.1 North America Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021)
6.3.2 North America Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027)
6.3.3 North America Nuclear Receptor ROR-Gamma Market Size by Application (2016-2027)
6.4 North America Nuclear Receptor ROR-Gamma Market Size by Country
6.4.1 North America Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021)
6.4.2 North America Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nuclear Receptor ROR-Gamma Market Size (2016-2027)
7.2 Europe Nuclear Receptor ROR-Gamma Market Size by Type
7.2.1 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021)
7.2.2 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027)
7.2.3 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2016-2027)
7.3 Europe Nuclear Receptor ROR-Gamma Market Size by Application
7.3.1 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021)
7.3.2 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027)
7.3.3 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2016-2027)
7.4 Europe Nuclear Receptor ROR-Gamma Market Size by Country
7.4.1 Europe Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021)
7.4.2 Europe Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size (2016-2027)
8.2 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Type
8.2.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Type (2016-2027)
8.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Application
8.3.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Application (2016-2027)
8.4 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region
8.4.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nuclear Receptor ROR-Gamma Market Size (2016-2027)
9.2 Latin America Nuclear Receptor ROR-Gamma Market Size by Type
9.2.1 Latin America Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021)
9.2.2 Latin America Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027)
9.2.3 Latin America Nuclear Receptor ROR-Gamma Market Size by Type (2016-2027)
9.3 Latin America Nuclear Receptor ROR-Gamma Market Size by Application
9.3.1 Latin America Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021)
9.3.2 Latin America Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027)
9.3.3 Latin America Nuclear Receptor ROR-Gamma Market Size by Application (2016-2027)
9.4 Latin America Nuclear Receptor ROR-Gamma Market Size by Country
9.4.1 Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021)
9.4.2 Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size (2016-2027)
10.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type
10.2.1 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2016-2027)
10.3 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application
10.3.1 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2016-2027)
10.4 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country
10.4.1 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 4SC AG
11.1.1 4SC AG Company Details
11.1.2 4SC AG Business Overview
11.1.3 4SC AG Nuclear Receptor ROR-Gamma Introduction
11.1.4 4SC AG Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.1.5 4SC AG Recent Development
11.2 Advinus Therapeutics Ltd.
11.2.1 Advinus Therapeutics Ltd. Company Details
11.2.2 Advinus Therapeutics Ltd. Business Overview
11.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Introduction
11.2.4 Advinus Therapeutics Ltd. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.2.5 Advinus Therapeutics Ltd. Recent Development
11.3 Arrien Pharmaceuticals, LLC
11.3.1 Arrien Pharmaceuticals, LLC Company Details
11.3.2 Arrien Pharmaceuticals, LLC Business Overview
11.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Introduction
11.3.4 Arrien Pharmaceuticals, LLC Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.3.5 Arrien Pharmaceuticals, LLC Recent Development
11.4 Aurigene Discovery Technologies Limited
11.4.1 Aurigene Discovery Technologies Limited Company Details
11.4.2 Aurigene Discovery Technologies Limited Business Overview
11.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Introduction
11.4.4 Aurigene Discovery Technologies Limited Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.4.5 Aurigene Discovery Technologies Limited Recent Development
11.5 Biogen, Inc.
11.5.1 Biogen, Inc. Company Details
11.5.2 Biogen, Inc. Business Overview
11.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Introduction
11.5.4 Biogen, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.5.5 Biogen, Inc. Recent Development
11.6 Brickell Biotech, Inc.
11.6.1 Brickell Biotech, Inc. Company Details
11.6.2 Brickell Biotech, Inc. Business Overview
11.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Introduction
11.6.4 Brickell Biotech, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.6.5 Brickell Biotech, Inc. Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.7.5 Bristol-Myers Squibb Company Recent Development
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Details
11.8.2 Celgene Corporation Business Overview
11.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Introduction
11.8.4 Celgene Corporation Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.8.5 Celgene Corporation Recent Development
11.9 Genentech, Inc.
11.9.1 Genentech, Inc. Company Details
11.9.2 Genentech, Inc. Business Overview
11.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Introduction
11.9.4 Genentech, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.9.5 Genentech, Inc. Recent Development
11.10 Genfit SA
11.10.1 Genfit SA Company Details
11.10.2 Genfit SA Business Overview
11.10.3 Genfit SA Nuclear Receptor ROR-Gamma Introduction
11.10.4 Genfit SA Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.10.5 Genfit SA Recent Development
11.11 GlaxoSmithKline Plc
11.11.1 GlaxoSmithKline Plc Company Details
11.11.2 GlaxoSmithKline Plc Business Overview
11.11.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Introduction
11.11.4 GlaxoSmithKline Plc Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.11.5 GlaxoSmithKline Plc Recent Development
11.12 Hanmi Pharmaceuticals, Co. Ltd.
11.12.1 Hanmi Pharmaceuticals, Co. Ltd. Company Details
11.12.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
11.12.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Introduction
11.12.4 Hanmi Pharmaceuticals, Co. Ltd. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.12.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Development
11.13 Karo Bio AB
11.13.1 Karo Bio AB Company Details
11.13.2 Karo Bio AB Business Overview
11.13.3 Karo Bio AB Nuclear Receptor ROR-Gamma Introduction
11.13.4 Karo Bio AB Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.13.5 Karo Bio AB Recent Development
11.14 Lead Pharma Holding B.V.
11.14.1 Lead Pharma Holding B.V. Company Details
11.14.2 Lead Pharma Holding B.V. Business Overview
11.14.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Introduction
11.14.4 Lead Pharma Holding B.V. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.14.5 Lead Pharma Holding B.V. Recent Development
11.15 Nuevolution AB
11.15.1 Nuevolution AB Company Details
11.15.2 Nuevolution AB Business Overview
11.15.3 Nuevolution AB Nuclear Receptor ROR-Gamma Introduction
11.15.4 Nuevolution AB Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.15.5 Nuevolution AB Recent Development
11.16 Phenex Pharmaceuticals AG
11.16.1 Phenex Pharmaceuticals AG Company Details
11.16.2 Phenex Pharmaceuticals AG Business Overview
11.16.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Introduction
11.16.4 Phenex Pharmaceuticals AG Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.16.5 Phenex Pharmaceuticals AG Recent Development
11.17 Reata Pharmaceuticals, Inc.
11.17.1 Reata Pharmaceuticals, Inc. Company Details
11.17.2 Reata Pharmaceuticals, Inc. Business Overview
11.17.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Introduction
11.17.4 Reata Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.17.5 Reata Pharmaceuticals, Inc. Recent Development
11.18 Teijin Pharma Limited
11.18.1 Teijin Pharma Limited Company Details
11.18.2 Teijin Pharma Limited Business Overview
11.18.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Introduction
11.18.4 Teijin Pharma Limited Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.18.5 Teijin Pharma Limited Recent Development
11.18 Visionary Pharmaceuticals, Inc.
.1 Visionary Pharmaceuticals, Inc. Company Details
.2 Visionary Pharmaceuticals, Inc. Business Overview
.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Introduction
.4 Visionary Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
.5 Visionary Pharmaceuticals, Inc. Recent Development
11.20 Vitae Pharmaceuticals, Inc.
11.20.1 Vitae Pharmaceuticals, Inc. Company Details
11.20.2 Vitae Pharmaceuticals, Inc. Business Overview
11.20.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Introduction
11.20.4 Vitae Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.20.5 Vitae Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of VPR-66
Table 3. Key Players of INV-17
Table 4. Key Players of GSK-2981278
Table 5. Key Players of BBI-6000
Table 6. Key Players of Others
Table 7. Global Nuclear Receptor ROR-Gamma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Nuclear Receptor ROR-Gamma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Nuclear Receptor ROR-Gamma Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Nuclear Receptor ROR-Gamma Market Share by Regions (2016-2021)
Table 11. Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Nuclear Receptor ROR-Gamma Market Share by Regions (2022-2027)
Table 13. Nuclear Receptor ROR-Gamma Market Trends
Table 14. Nuclear Receptor ROR-Gamma Market Drivers
Table 15. Nuclear Receptor ROR-Gamma Market Challenges
Table 16. Nuclear Receptor ROR-Gamma Market Restraints
Table 17. Global Nuclear Receptor ROR-Gamma Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Nuclear Receptor ROR-Gamma Market Share by Players (2016-2021)
Table 19. Global Top Nuclear Receptor ROR-Gamma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Receptor ROR-Gamma as of 2020)
Table 20. Ranking of Global Top Nuclear Receptor ROR-Gamma Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Nuclear Receptor ROR-Gamma Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nuclear Receptor ROR-Gamma Product Solution and Service
Table 24. Date of Enter into Nuclear Receptor ROR-Gamma Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2016-2021)
Table 28. Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Nuclear Receptor ROR-Gamma Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2016-2021)
Table 32. Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027) & (US$ Million)
Table 64. 4SC AG Company Details
Table 65. 4SC AG Business Overview
Table 66. 4SC AG Nuclear Receptor ROR-Gamma Product
Table 67. 4SC AG Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 68. 4SC AG Recent Development
Table 69. Advinus Therapeutics Ltd. Company Details
Table 70. Advinus Therapeutics Ltd. Business Overview
Table 71. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product
Table 72. Advinus Therapeutics Ltd. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 73. Advinus Therapeutics Ltd. Recent Development
Table 74. Arrien Pharmaceuticals, LLC Company Details
Table 75. Arrien Pharmaceuticals, LLC Business Overview
Table 76. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product
Table 77. Arrien Pharmaceuticals, LLC Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 78. Arrien Pharmaceuticals, LLC Recent Development
Table 79. Aurigene Discovery Technologies Limited Company Details
Table 80. Aurigene Discovery Technologies Limited Business Overview
Table 81. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product
Table 82. Aurigene Discovery Technologies Limited Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 83. Aurigene Discovery Technologies Limited Recent Development
Table 84. Biogen, Inc. Company Details
Table 85. Biogen, Inc. Business Overview
Table 86. Biogen, Inc. Nuclear Receptor ROR-Gamma Product
Table 87. Biogen, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 88. Biogen, Inc. Recent Development
Table 89. Brickell Biotech, Inc. Company Details
Table 90. Brickell Biotech, Inc. Business Overview
Table 91. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product
Table 92. Brickell Biotech, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 93. Brickell Biotech, Inc. Recent Development
Table 94. Bristol-Myers Squibb Company Company Details
Table 95. Bristol-Myers Squibb Company Business Overview
Table 96. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product
Table 97. Bristol-Myers Squibb Company Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 98. Bristol-Myers Squibb Company Recent Development
Table 99. Celgene Corporation Company Details
Table 100. Celgene Corporation Business Overview
Table 101. Celgene Corporation Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 102. Celgene Corporation Recent Development
Table 103. Genentech, Inc. Company Details
Table 104. Genentech, Inc. Business Overview
Table 105. Genentech, Inc. Nuclear Receptor ROR-Gamma Product
Table 106. Genentech, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 107. Genentech, Inc. Recent Development
Table 108. Genfit SA Company Details
Table 109. Genfit SA Business Overview
Table 110. Genfit SA Nuclear Receptor ROR-Gamma Product
Table 111. Genfit SA Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 112. Genfit SA Recent Development
Table 113. GlaxoSmithKline Plc Company Details
Table 114. GlaxoSmithKline Plc Business Overview
Table 115. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product
Table 116. GlaxoSmithKline Plc Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 117. GlaxoSmithKline Plc Recent Development
Table 118. Hanmi Pharmaceuticals, Co. Ltd. Company Details
Table 119. Hanmi Pharmaceuticals, Co. Ltd. Business Overview
Table 120. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product
Table 121. Hanmi Pharmaceuticals, Co. Ltd. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 122. Hanmi Pharmaceuticals, Co. Ltd. Recent Development
Table 123. Karo Bio AB Company Details
Table 124. Karo Bio AB Business Overview
Table 125. Karo Bio AB Nuclear Receptor ROR-Gamma Product
Table 126. Karo Bio AB Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 127. Karo Bio AB Recent Development
Table 128. Lead Pharma Holding B.V. Company Details
Table 129. Lead Pharma Holding B.V. Business Overview
Table 130. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product
Table 131. Lead Pharma Holding B.V. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 132. Lead Pharma Holding B.V. Recent Development
Table 133. Nuevolution AB Company Details
Table 134. Nuevolution AB Business Overview
Table 135. Nuevolution AB Nuclear Receptor ROR-Gamma Product
Table 136. Nuevolution AB Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 137. Nuevolution AB Recent Development
Table 138. Phenex Pharmaceuticals AG Company Details
Table 139. Phenex Pharmaceuticals AG Business Overview
Table 140. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product
Table 141. Phenex Pharmaceuticals AG Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 142. Phenex Pharmaceuticals AG Recent Development
Table 143. Reata Pharmaceuticals, Inc. Company Details
Table 144. Reata Pharmaceuticals, Inc. Business Overview
Table 145. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product
Table 146. Reata Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 147. Reata Pharmaceuticals, Inc. Recent Development
Table 148. Teijin Pharma Limited Company Details
Table 149. Teijin Pharma Limited Business Overview
Table 150. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product
Table 151. Teijin Pharma Limited Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 152. Teijin Pharma Limited Recent Development
Table 153. Visionary Pharmaceuticals, Inc. Company Details
Table 154. Visionary Pharmaceuticals, Inc. Business Overview
Table 155. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product
Table 156. Visionary Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 157. Visionary Pharmaceuticals, Inc. Recent Development
Table 158. Vitae Pharmaceuticals, Inc. Company Details
Table 159. Vitae Pharmaceuticals, Inc. Business Overview
Table 160. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product
Table 161. Vitae Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 162. Vitae Pharmaceuticals, Inc. Recent Development
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Receptor ROR-Gamma Market Share by Type: 2020 VS 2027
Figure 2. VPR-66 Features
Figure 3. INV-17 Features
Figure 4. GSK-2981278 Features
Figure 5. BBI-6000 Features
Figure 6. Others Features
Figure 7. Global Nuclear Receptor ROR-Gamma Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Nuclear Receptor ROR-Gamma Report Years Considered
Figure 12. Global Nuclear Receptor ROR-Gamma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Nuclear Receptor ROR-Gamma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Nuclear Receptor ROR-Gamma Market Share by Regions: 2020 VS 2027
Figure 15. Global Nuclear Receptor ROR-Gamma Market Share by Regions (2022-2027)
Figure 16. Global Nuclear Receptor ROR-Gamma Market Share by Players in 2020
Figure 17. Global Top Nuclear Receptor ROR-Gamma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Receptor ROR-Gamma as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Nuclear Receptor ROR-Gamma Revenue in 2020
Figure 19. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2016-2021)
Figure 20. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2022-2027)
Figure 21. North America Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Nuclear Receptor ROR-Gamma Market Share by Type (2016-2027)
Figure 23. North America Nuclear Receptor ROR-Gamma Market Share by Application (2016-2027)
Figure 24. North America Nuclear Receptor ROR-Gamma Market Share by Country (2016-2027)
Figure 25. United States Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Nuclear Receptor ROR-Gamma Market Share by Type (2016-2027)
Figure 29. Europe Nuclear Receptor ROR-Gamma Market Share by Application (2016-2027)
Figure 30. Europe Nuclear Receptor ROR-Gamma Market Share by Country (2016-2027)
Figure 31. Germany Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Nuclear Receptor ROR-Gamma Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Nuclear Receptor ROR-Gamma Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Nuclear Receptor ROR-Gamma Marke
  • Global Posaconazole Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 131
    Posaconazole is an antifungal medicine that fights certain infections caused by fungus. Posaconazole is used to prevent fungal infections in people who have a weak immune system resulting from certain treatments or conditions (such as chemotherapy, stem cell transplantation, HIV infection, and others). Market Analysis and Insights: Global Posaconazole Market The global Posaconazole market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing......
  • Global Fluconazole Drug Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 148
    Fluconazole is an antifungal medicine. Fluconazole is used to treat infections caused by fungus, which can invade any part of the body including the mouth, throat, esophagus, lungs, bladder, genital area, and the blood. Market Analysis and Insights: Global Fluconazole Drug Market The global Fluconazole Drug market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Fluconazole Drug S......
  • Global Itraconazole Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 140
    Itraconazole is an antifungal medication used to treat a number of fungal infections. This includes aspergillosis, blastomycosis, coccidioidomycosis, histoplasmosis, and paracoccidioidomycosis. It may be given by mouth or intravenously. Common side effects include nausea, diarrhea, abdominal pain, rash, and headache. Market Analysis and Insights: Global Itraconazole Market The global Itraconazole market was valued at US$ XX in 2020 and will reach US$ XX million by the end o......
  • Global Lasix Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 136
    Lasix is a medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. It may also be used for the treatment of high blood pressure. It can be taken by injection into a vein or by mouth. Market Analysis and Insights: Global Lasix Market The global Lasix market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Lasix Scope and Market Size T......
  • Global Albendazole Drug Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 131
    Albendazole is a medication used for the treatment of a variety of parasitic worm infestations. It is useful for giardiasis, trichuriasis, filariasis, neurocysticercosis, hydatid disease, pinworm disease, and ascariasis, among others. It is taken by mouth. Market Analysis and Insights: Global Albendazole Drug Market The global Albendazole Drug market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.......
  • Global Cyromazine Drug Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 136
    Cyromazine has CAS No. 66215-27-8, Mol. Wt. 166.18gms/mol, Molecular formula C6 H10N6 . Cyromazine acts as an effective antiparasitic agent for Veterinary use to control diseases like Scabies, Pediculosis etc. These diseases are called as Ectoparasitic diseases which need an effective Ectoparasiticide, that is an anti-ectoparasitic like Cyromazine that attacks parasites like ticks , leeches which live on the surface of the animal and suck their blood. Hence it is used to control the growth of su......
  • Global Veterinary Autogenous Vaccines Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 143
    The autogenous vaccine is a vaccine prepared from cultures of microorganisms obtained from an individual and then used to immunize that same individual against further spread and progress of the same microorganisms. Market Analysis and Insights: Global Veterinary Autogenous Vaccines Market The global Veterinary Autogenous Vaccines market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. G......
  • Global Bone Growth Stimulant Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 134
    Market Analysis and Insights: Global Bone Growth Stimulant Market The global Bone Growth Stimulant market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Bone Growth Stimulant Scope and Market Size The global Bone Growth Stimulant market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bone Growth Stimulan......
  • Global Aticaine Hydrochloride Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 138
    Market Analysis and Insights: Global Aticaine Hydrochloride Market The global Aticaine Hydrochloride market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Aticaine Hydrochloride Scope and Market Size The global Aticaine Hydrochloride market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Aticaine Hydroch......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs